期刊文献+

甘利欣对大鼠肺纤维化的治疗作用及对血清IL4/IFN-γ浓度的影响 被引量:11

Role of glycyrrhizin in the treatment of pulmonary fibrosis in rats and impact of this agent on serum IL4/IFN-γ level
下载PDF
导出
摘要 目的:研究甘利欣对大鼠肺纤维化的治疗作用及对血清IL4/IFN-γ浓度的影响。方法:40只SD大鼠随机分为对照组、模型组、甘草甜素治疗组、地塞米松组。气管内注入博莱霉素造成动物模型28d后,开始每天甘利欣、地塞米松腹腔给药,于43d时(用药15d后)处死,取肺组织行嗜伊红染色观察肺纤维化程度;肺组织匀浆中羟脯氨酸(HYP)含量,血清测IL4、IFN-γ的浓度。结果:甘利欣治疗后,肺纤维化程度、肺组织匀浆中羟脯氨酸(HYP)含量较模型组减轻;与地塞米松组相仿。甘利欣治疗组血清IL4水平比模型组低,血清IFN-γ水平较模型组与地塞米松组相仿。结论:甘利欣可以减轻博莱霉素诱导的大鼠肺纤维化程度,其机制可能与IL4/IFN-γ有关。 Objective To explore the role of glyeyrrhizin in the treatment of pulmonary fibrosis in rats and the effect of this agent on serum IL4/IFN-γ level. Methods 40 rats were randomly divided into control group, model group,glycyrrhizin group,and dexamethison group.28 days after the establishment of the rat model of pulmonary fibrosis by intratracheal injections of bleomycin,the rats in the two treatment groups received intraperitoneal injections of glyeyrrhizin or dexamethison, and then were sacrificed on day 43. Pathological changes in the lungs were measured by HE staining. The hydroxyprollne content in lung tissue homogenate and serum levels of IL4 and IFN-γ were detected. Results As compared with the model group, the degree of pulmonary fibrosis and the hydroxyproline content decreased in glycyrrhizin group. Serum IL4 level was lower in glyeyrrhizin group than in the model group, whereas IFN-γ level was higher; similar to those in dexamethison group. Conclusions Glycyrrhizin can alleviate the degree of pulmonary fibrosis induced by bleomycin in rats, whose maehanism may be associated with a change in levels of IL4 and IFN-γ.
出处 《实用医学杂志》 CAS 北大核心 2011年第6期960-962,共3页 The Journal of Practical Medicine
基金 浙江省中医药管理局课题(编号:2006C176) 温州市科技局课题(编号:Y20060134)
关键词 肺纤维化 甘利欣 博来霉素 IL4/IFN-γ Glycyrrhizin Pulmonary fibrosis Bleomycin IL4/IFN-γ
  • 相关文献

参考文献3

二级参考文献103

  • 1Raghu G,Weycker D,Edelsberg J,Bradford WZ,Oster G.Incidence and prevalence of idiopathic pulmonary fibrosis.Am J Respire Crit Care Med 2006;174:810-816.
  • 2Olsen AL,Swigris JJ,Lezotte DC,Norris JM,Wilson CG,Brown KK.Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.Am J Respir Crit Case Med 2007;176:277-284.
  • 3Crystal RG,Bitteoman PB,Mossman B,Schwarz MI,Sheppard D,Almasy L,et al.Future research directions in idiopathic pulmonary fibrosis:summary of a National Heart,Lung,and Blood Institute working group.Am J Respire Crit Care Med 2002;166:236-246.
  • 4Moss M.Clinical year in review II.Interstitial lung disease,sepsis,pubnonary infections,and sleep medicine.Proc Am Thorax Soc 2007;4:482-488.
  • 5Noble PW,Homer RJ.Back to the future historical perspective on the pathogenesis of idiopathic palmary fibrosis.Am J Respire Cell Mol Biol 2005;33:113-120.
  • 6Scotton C,J,Chambers RC.Molecular targets in pulmonary fibrosis.The myofrroblast in focus.Chest 2007;132:1311-1312.
  • 7Tharmickal V J,Toews GB,White ES,Lynch JP 3rd,Maninez FJ.Mechanisms of pulmonary fibrosis.Annu Rev Med 2004;55:395-417.
  • 8Huminghake GW,Schwarz MI.Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis.Proc Am Thorax Soc 2007;4:449-452.
  • 9Eickelberg O,Panskg A,Koebler E,Bihl M,Tamm M,Hildebrand P,et al.Molecular mechanisms of TGF-βantagonism by interferon r and cyclosporine A in lung fibroblasts.FASEB J 2001;15:797-806.
  • 10Selman M,Thanmickal V J,Pardo A,Zisman DA,Martinez FJ,Lynch JP 3rd.Idiopathic pulmonary fibrosis.Pathogenesis and therapeutic approaches.Drug 2004;64:405-430.

共引文献51

同被引文献204

引证文献11

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部